TARGINIQ (naloxone hydrochloride; oxycodone hydrochloride) Purdue pharma lp Patent: 8,846,090 Expiration: Apr 4, 2023 See More … For more information […]
Drug Patent Expirations for the Week of April 2, 2023 Read Post »
Annual Drug Patent Expirations for TARGINIQ Targiniq is a drug marketed by Purdue Pharma Lp and is included in one
New patent expiration for Purdue Pharma drug TARGINIQ Read Post »
Annual Drug Patent Expirations for GLUMETZA Glumetza is a drug marketed by Santarus Inc and is included in one NDA.
New patent expiration for Santarus Inc drug GLUMETZA Read Post »
REYVOW (lasmiditan succinate) Eli lilly and co Patent: 8,748,459 Expiration: Mar 27, 2023 See More … For more information on
Drug Patent Expirations for the Week of March 26, 2023 Read Post »
Annual Drug Patent Expirations for VENLAFAXINE+BESYLATE Venlafaxine Besylate is a drug marketed by Almatica and is included in one NDA.
New patent expiration for Almatica drug VENLAFAXINE BESYLATE Read Post »
Annual Drug Patent Expirations for AFINITOR+DISPERZ Afinitor Disperz is a drug marketed by Novartis Pharm and is included in one
New patent expiration for Novartis Pharm drug AFINITOR DISPERZ Read Post »
Annual Drug Patent Expirations for REYVOW Reyvow is a drug marketed by Eli Lilly And Co and is included in
Annual Drug Patent Expirations for XELJANZ+XR Xeljanz Xr is a drug marketed by Pfizer and is included in one NDA.
New patent expiration for Pfizer drug XELJANZ XR Read Post »
Annual Drug Patent Expirations for ABILIFY Abilify is a drug marketed by Otsuka and Otsuka Pharm Co Ltd and is
Get fresh news and insights, drug patent expirations & more…
